Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression

Not yet recruitingOBSERVATIONAL
Enrollment

477

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 30, 2025

Conditions
Non-small Cell Lung Cancer
Interventions
GENETIC

GSTP1 A313G (AA)

Patients with pulmonary malignant tumors receiving platinum-containing chemotherapy regimen were included in the retrospective and prospective bidirectional cohort study to collect the basic information of the subjects, including gender, age, smoking history, primary site, basic liver and kidney function, chemotherapy regimen, etc. The polymorphisms of glutathione S transferase (GSTP1 A313G) were detected by Sanger dideoxy termination sequencing. The wild type (AA) and mutant type (AG/GG) were divided into two groups.

All Listed Sponsors
lead

LI YAN

OTHER

NCT06140082 - Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression | Biotech Hunter | Biotech Hunter